GlassScriptPhysician profile
Kailey Evasic
NPI 1649987488
$2,415.34
in general payments reported to CMS, 2019-2025
16 companies · $180 in 2025
The $180 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $59.91 · 2023: $641 · 2024: $1,535 · 2025: $180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,410 · Travel and Lodging: $945.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,410.38 |
| Travel and Lodging | $945.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle, INC | $695.00 | 2024 | |
| Arthrex, INC. | $650.30 | 2024 | |
| Stryker Corporation | $163.31 | 2025 | Pangea |
| Astrazeneca Pharmaceuticals LP | $146.68 | 2023-2025 | Farxiga, Breztri |
| Novo Nordisk INC | $145.47 | 2023-2024 | Ozempic, Rybelsus |
| Lilly USA, LLC | $140.02 | 2022-2024 | Mounjaro |
| Abbvie INC. | $115.13 | 2023-2024 | |
| Glaxosmithkline, LLC. | $76.85 | 2023-2024 | Trelegy Ellipta, Arexvy |
| Otsuka America Pharmaceutical, INC. | $74.72 | 2023 | Rexulti, Abilify Maintena |
| Pfizer INC. | $67.00 | 2023 | |
| Exact Sciences Corporation | $33.89 | 2023 | Cologuard Collection Kit |
| Depuy Synthes Sales INC. | $26.36 | 2024 | Na, Vivigen Mis Delivery System |
| Seqirus USA INC | $24.15 | 2023 | Flucelvax Quadrivalent, Fluad Quadrivalent |
| Idorsia Pharmaceuticals US INC | $21.72 | 2023 | Quviviq |
| Biohaven Pharmaceutical Holding Company LTD. | $20.96 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $13.78 | 2024 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kailey Evasic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.